China National Accord Medicines Corporation Ltd.

SZSE:000028 Stock Report

Market Cap: CN¥15.5b

China National Accord Medicines Past Earnings Performance

Past criteria checks 2/6

China National Accord Medicines has been growing earnings at an average annual rate of 4.9%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 8.2% per year. China National Accord Medicines's return on equity is 7.4%, and it has net margins of 2%.

Key information

4.9%

Earnings growth rate

4.9%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate8.2%
Return on equity7.4%
Net Margin2.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

Nov 18
Lacklustre Performance Is Driving China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E

China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 30
China National Accord Medicines Corporation Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

Oct 10
China National Accord Medicines (SZSE:000028) Seems To Use Debt Quite Sensibly

China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Aug 13
China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Low P/E No Reason For Excitement

Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Jul 12
Estimating The Intrinsic Value Of China National Accord Medicines Corporation Ltd. (SZSE:000028)

Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Jun 12
Is China National Accord Medicines (SZSE:000028) A Risky Investment?

Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

May 12
Improved Earnings Required Before China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Find Their Feet

Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

Apr 10
Analysts Are Updating Their China National Accord Medicines Corporation Ltd. (SZSE:000028) Estimates After Its Full-Year Results

China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

Mar 15
China National Accord Medicines Corporation Ltd. (SZSE:000028) Shares Could Be 28% Below Their Intrinsic Value Estimate

China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Feb 29
China National Accord Medicines (SZSE:000028) Has A Rock Solid Balance Sheet

Revenue & Expenses Breakdown

How China National Accord Medicines makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SZSE:000028 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2475,3581,4756,50128
30 Jun 2474,8761,5126,47428
31 Mar 2475,8811,6266,46131
31 Dec 2375,4771,5996,48027
30 Sep 2375,4121,6296,55027
30 Jun 2375,7021,6436,55421
31 Mar 2374,9791,5976,47611
31 Dec 2273,4431,4876,3969
30 Sep 2272,7651,3106,1210
30 Jun 2271,3241,2696,0240
31 Mar 2269,4591,2605,9740
31 Dec 2168,3581,3365,8160
30 Sep 2166,9791,4785,7580
30 Jun 2165,6431,5005,5820
31 Mar 2162,8751,4825,2050
31 Dec 2059,6491,4024,9460
30 Sep 2056,2441,3064,5360
30 Jun 2054,3581,2624,2680
31 Mar 2053,5391,2174,1640
31 Dec 1952,7871,2684,0200
30 Sep 1950,7791,2433,9810
30 Jun 1947,9431,2183,8370
31 Mar 1944,9371,2173,6810
31 Dec 1843,1221,2113,5250
30 Sep 1841,7511,1823,3160
30 Jun 1841,5171,1433,2050
31 Mar 1841,2981,0783,0870
31 Dec 1741,2631,0583,0300
30 Sep 1741,4181,0802,9730
30 Jun 1741,2111,0842,9930
31 Mar 1741,1591,2052,9790
31 Dec 1641,2481,1873,0270
30 Sep 1649,2491,2634,4520
30 Jun 1645,5681,1993,9260
31 Mar 1641,8709843,4150
31 Dec 1537,8199282,8990
30 Sep 1525,7407219740
30 Jun 1525,1556939410
31 Mar 1524,6836829900
31 Dec 1423,9546529760
30 Sep 1423,4186299440
30 Jun 1422,6806079490
31 Mar 1421,8645459110
31 Dec 1321,1995208860

Quality Earnings: 000028 has high quality earnings.

Growing Profit Margin: 000028's current net profit margins (2%) are lower than last year (2.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 000028's earnings have grown by 4.9% per year over the past 5 years.

Accelerating Growth: 000028's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 000028 had negative earnings growth (-9.4%) over the past year, making it difficult to compare to the Healthcare industry average (-5.7%).

Return on Equity

High ROE: 000028's Return on Equity (7.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China National Accord Medicines Corporation Ltd. is covered by 27 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lei TianAJ Securities Co., Ltd
Shuchang LiuChangjiang Securities Co. LTD.
Yanyin ZhuChina International Capital Corporation Limited